Understanding what proteins are present in cancers is fundamental for drug development and therapeutic treatments.

For the past few decades, cancer research advanced greatly due to genomics and now proteomics is presenting many new opportunities for advancement.

• Proteins are better at representing real-time conditions in the body
• Proteins in humans are more diverse than genes
• Proteins give a better understanding of the pathobiology of diseases

While these are great opportunities, there are also challenges that have been brought forward with proteomic biomarker discovery.

• Quality and quantity of samples
• Experimental study design
• Dynamic range of proteins
• Quality of data

We have put together a bundle that calls out these challenges and an introduction to a technology that can help to overcome them.